Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plasma colloid oncotic pressure is the osmotic pressure generated by plasma proteins, primarily albumin, in the blood. This force pulls water into the circulatory system, counterbalancing hydrostatic pressure and maintaining fluid balance between blood vessels and interstitial spaces. Reduced oncotic pressure, often due to hypoalbuminemia, can lead to edema. It is a critical parameter in fluid management, especially in critically ill patients.
Influenced by drugs that affect plasma protein concentration, such as albumin infusions which increase oncotic pressure.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasma Colloid Oncotic Pressure (PCOP).